Jefferies Financial Group Inc. bought a new stake in Clarivate PLC (NYSE:CLVT – Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 254,557 shares of the company’s stock, valued at approximately $425,000.
Other hedge funds have also made changes to their positions in the company. First Trust Advisors LP increased its position in Clarivate by 10.3% in the 1st quarter. First Trust Advisors LP now owns 5,522,601 shares of the company’s stock valued at $13,972,000 after acquiring an additional 516,418 shares during the period. KBC Group NV purchased a new stake in Clarivate during the 1st quarter valued at approximately $4,118,000. Arrowstreet Capital Limited Partnership purchased a new stake in Clarivate during the 1st quarter valued at approximately $3,342,000. Empowered Funds LLC raised its stake in Clarivate by 418.6% during the 1st quarter. Empowered Funds LLC now owns 2,015,829 shares of the company’s stock valued at $5,100,000 after acquiring an additional 1,627,159 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new stake in Clarivate during the 1st quarter valued at approximately $1,159,000. Institutional investors and hedge funds own 85.72% of the company’s stock.
Clarivate Price Performance
Shares of NYSE:CLVT opened at $2.31 on Monday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.92. The company has a market cap of $1.48 billion, a P/E ratio of -3.80 and a beta of 1.38. Clarivate PLC has a 52 week low of $1.42 and a 52 week high of $3.87. The company has a 50-day moving average price of $1.85 and a 200 day moving average price of $2.19.
Clarivate (NYSE:CLVT – Get Free Report) last released its earnings results on Wednesday, November 4th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.03. The company had revenue of $481.60 million for the quarter, compared to analysts’ expectations of $566.77 million. Clarivate had a positive return on equity of 9.84% and a negative net margin of 17.02%. The firm’s quarterly revenue was down 22.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.18 EPS. Research analysts predict that Clarivate PLC will post 0.67 earnings per share for the current year.
Analyst Ratings Changes
Several research analysts have weighed in on CLVT shares. Barclays lowered their target price on Clarivate from $2.50 to $2.00 and set an “underweight” rating on the stock in a research note on Thursday, July 30th. The Goldman Sachs Group dropped their target price on Clarivate from $2.60 to $2.30 and set a “neutral” rating on the stock in a report on Thursday, November 5th. William Blair cut Clarivate to a “market perform” rating in a research note on Thursday, October 15th. Jefferies Financial Group reaffirmed a “hold” rating and set a $2.25 price target on shares of Clarivate in a report on Thursday, November 5th. Finally, Wall Street Zen downgraded Clarivate from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. One analyst has rated the stock with a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Clarivate presently has a consensus rating of “Reduce” and an average target price of $2.65.
View Our Latest Stock Analysis on Clarivate
About Clarivate
Clarivate provides information, analytics and workflow tools to customers in academia and government, life sciences and healthcare, and intellectual property. Its services help organizations find and analyze research, assess scientific and commercial developments, and manage patents, trademarks and other intellectual property. Its products include Web of Science and ProQuest research resources, Cortellis life sciences intelligence, and intellectual property databases and services such as Derwent.
See Also
- Five stocks we like better than Clarivate
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.
